Business EconomyPosted at: Nov 12 2025 12:41AM


Granules Life Sciences gets first U.S. FDA approval for Hyderabad Facility

Hyderabad, Nov 11 (UNI) Granules India Limited, on Tuesday announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), located here, has received U.S. Food and Drug Administration (FDA) approval for a product that was the subject of a Pre-Approval Inspection (PAI) conducted between July 28 and August 1.
There was one observation during that inspection, and the GLS had submitted its response within the stipulated time.
With this approval, the GLS facility is now deemed approved by the U.S. FDA, marking a major milestone for Granules India as it expands its finished dosage manufacturing capabilities. This is the first FDA approval for the GLS site, the Hyderabad pharma said in a release here.
The company plans to launch the approved product in the U.S. market soon. The same product is already approved and manufactured at Granules’ Gagillapur facility. The new approval will help strengthen market share and support business continuity through multi-site manufacturing.
“We plan on launching the product into the U.S. market soon. It is an already approved product at our Gagillapur facility, but we plan on building market share with this approval,” said Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited.
“We also have other products filed from this site and expect the U.S. FDA to approve them following necessary audits if required. This marks the first approval from our second Hyderabad facility with finished dosage capabilities,” he added.
UNI KNR SSP
Please log in to get detailed story.
Tags: #Granules Life Sciences gets first U.S. FDA approval for Hyderabad Facility
More News

Brookfield, FedEx to set up GCCs in Mumbai

14 Dec 2025 | 1:39 AM

Mumbai, Dec 13 (UNI) Global alternative asset management and investment firm, Brookfield as well as FedEx Corporation plan to set up Asia’s largest global capability centre (GCC) in Mumbai, Maharashtra Chief Minister Devendra Fadnavis has announced.

see more..

Kerala boasts cost-effective ecosystem of space vendors: Experts at Huddle Global 2025

14 Dec 2025 | 1:02 AM

Thiruvananthapuram, Dec 13 (UNI) Kerala has a very cost-effective and mature ecosystem of space vendors that would help the country become a global vendor in the sector, said experts today at Huddle Global 2025.

see more..

AP: Ponduru Khadi from Srikakulam receives prestigious GI Tag

13 Dec 2025 | 8:22 PM

Srikakulam, (Andhra Pradesh), Dec 13 (UNI) After years of sustained efforts involving extensive documentation, meetings, and follow-ups, Ponduru Khadi, a traditional handwoven fabric from Srikakulam district, has been awarded the prestigious Geographical Indication (GI) tag, union Civil Aviation Minister Kinjarapu Ram Mohan Naidu on Saturday.
Ram Mohan Naidu, also a native of Srikakulam, expressed immense pride over the achievement.

see more..

SBI report flags marginal rise in inflation but sees comfort on prices and rates

13 Dec 2025 | 2:37 PM

New Delhi, Dec 13 (UNI) India’s retail inflation has shown a marginal reversal in November 2025 but remains at a comfortable level, with overall price pressures still muted, according to SBI Research’s latest Ecowrap report released on Saturday here.

see more..

Ozempic ® - world’s most prescribed GLP-1is now available in India

13 Dec 2025 | 4:02 AM

Hyderabad, Dec 12 (UNI) Novo Nordisk, a global healthcare company, on Friday announced the launch of its once-weekly diabetes drug Ozempic® (injectable semaglutide) in India, marking a significant addition to the country’s treatment options for type 2 diabetes.
The therapy, a GLP-1 receptor agonist, is approved as an adjunct to diet and exercise for adults with uncontrolled type 2 diabetes mellitus (T2DM).

see more..